Company / Current Assets
VitaNova Life Sciences Corp Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.3M
FY2025
5-year range
$0 / $2.3M
FY2021-FY2025
Trend
+89.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $8,728 to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2025 with a 3-year CAGR of +360.5%.
Improved from $8,728 to $2M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +360.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +360.5%, indicating consistent growth.
- In FY2025, current assets increased 89.1% year-over-year.
- Lowest current assets in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.3M | +89.1% |
| FY2024 | $1.2M | +13567.0% |
| FY2023 | $8.7K | -62.2% |
| FY2022 | $23.1K | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $4.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026